Dr. Vuori has served as a member of our Board since October 2021. Since January 2023, she has served as President and CEO and a member of the board of directors of Sanford Laboratories for Innovative Medicines, or Sanford Labs, an independent, not-for-profit biomedical research institution with a mission to discover and deliver the next-generation of molecular medicines. Since January 1995, Dr. Vuori has also served as Professor, and since January 2010 as Pauline and Stanley Foster Distinguished Chair, at the National Cancer Institute-designated Cancer Center, or Cancer Center, of Sanford Burnham Prebys Medical Discovery Institute, or SBP, a non-profit research organization with major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. In addition, Dr. Vuori served as President and a member of the board of directors of SBP from January 2010 to June 2022 and as SBP’s interim Chief Executive Officer from January 2013 to September 2014 and September 2017 to June 2020. She also served as SBP’s Executive Vice President for Scientific Affairs from 2008-2010, Director of the Cancer Center from 2005-2013, and Deputy Director of the Cancer Center from 2003-2005. Dr. Vuori has previously served or is currently serving on the board of directors of Bionano Genomics, Inc., Sio Gene Therapies, Inc., Forian Inc., WebMD Health Corp, Inc., the American Association for Cancer Research, the California Institute for Regenerative Medicine and the California Breast Cancer Research Program. Dr. Vuori received her M.D. and Ph.D. from the University of Oulu, Finland.
What is Kristiina Vuori's net worth?
The estimated net worth of Kristiina Vuori is at least $639.75 thousand as of September 10th, 2024. Dr. Vuori owns 7,319 shares of Inhibrx Biosciences stock worth more than $639,754 as of December 5th. This net worth estimate does not reflect any other investments that Dr. Vuori may own. Learn More about Kristiina Vuori's net worth.
How do I contact Kristiina Vuori?
Has Kristiina Vuori been buying or selling shares of Inhibrx Biosciences?
Kristiina Vuori has not been actively trading shares of Inhibrx Biosciences during the last ninety days. Most recently, on Tuesday, September 10th, Kristiina Md Vuori bought 179 shares of Inhibrx Biosciences stock. The stock was acquired at an average cost of $15.00 per share, with a total value of $2,685.00. Following the completion of the transaction, the director now directly owns 7,319 shares of the company's stock, valued at $109,785. Learn More on Kristiina Vuori's trading history.
Who are Inhibrx Biosciences' active insiders?
Are insiders buying or selling shares of Inhibrx Biosciences?
During the last twelve months, insiders at the sold shares 1 times. They sold a total of 350,000 shares worth more than $11,287,500.00. The most recent insider tranaction occured on October, 7th when Major Shareholder Global Investors Lp Viking sold 350,000 shares worth more than $11,287,500.00. Insiders at Inhibrx Biosciences own 17.1% of the company.
Learn More about insider trades at Inhibrx Biosciences. Information on this page was last updated on 10/7/2025.
